CRISPLD1
Cysteine-rich secretory protein LCCL domain-containing 1
Also known as: Cocoacrisp, CRLD1_HUMAN, DKFZp762F133, LCRISP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H336
- Gene
- CRISPLD1
- Ensembl
- ENSG00000121005
- Chromosome
- 8
- Canonical length
- 500 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Involved in face morphogenesis. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
500 residues, UniProt reviewed canonical sequence.
>Q9H336|CRISPLD1
1 MKCTAREWLR VTTVLFMARA IPAMVVPNAT LLEKLLEKYM DEDGEWWIAK QRGKRAITDN
61 DMQSILDLHN KLRSQVYPTA SNMEYMTWDV ELERSAESWA ESCLWEHGPA SLLPSIGQNL
121 GAHWGRYRPP TFHVQSWYDE VKDFSYPYEH ECNPYCPFRC SGPVCTHYTQ VVWATSNRIG
181 CAINLCHNMN IWGQIWPKAV YLVCNYSPKG NWWGHAPYKH GRPCSACPPS FGGGCRENLC
241 YKEGSDRYYP PREEETNEIE RQQSQVHDTH VRTRSDDSSR NEVISAQQMS QIVSCEVRLR
301 DQCKGTTCNR YECPAGCLDS KAKVIGSVHY EMQSSICRAA IHYGIIDNDG GWVDITRQGR
361 KHYFIKSNRN GIQTIGKYQS ANSFTVSKVT VQAVTCETTV EQLCPFHKPA SHCPRVYCPR
421 NCMQANPHYA RVIGTRVYSD LSSICRAAVH AGVVRNHGGY VDVMPVDKRK TYIASFQNGI
481 FSESLQNPPG GKAFRVFAVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRISPLD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 66 nTPM
- breast: 27 nTPM
- prostate: 23 nTPM
- parathyroid gland: 18 nTPM
- salivary gland: 18 nTPM
- ovary: 14 nTPM
Single-cell type
- prostatic glandular cells: 353 nCPM
- endometrial ciliated cells: 352 nCPM
- ependymal cells: 227 nCPM
- epididymal efferent duct ciliated cells: 147 nCPM
- breast myoepithelial cells: 116 nCPM
- oligodendrocyte progenitor cells: 83 nCPM
Immune cell
- plasmacytoid DC: 0.7 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 23 nTPM
- midbrain: 23 nTPM
- medulla oblongata: 19 nTPM
- hypothalamus: 18 nTPM
- spinal cord: 14 nTPM
- hippocampal formation: 9.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CRISPLD1.
Disease | ImmuneIEDB
Conditions an epitope on CRISPLD1 was assayed in.
- colon adenocarcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRISPLD1 as an antibody target. Whether an autoantibody or antibody against CRISPLD1 could matter depends on whether native CRISPLD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRISPLD1 is annotated as secreted, so native CRISPLD1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CRISPLD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...